Trial
NCT03755934
Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
—
Condition
Painful Diabetic Neuropathy
Intervention
MEDI7352
Why stopped
The study was prematurely terminated due to longer enrolment time than was anticipated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19